Buffet at the Gates

Gates Foundation

Major changes are coming to the organization that is fundamentally changing global health, by which I mean the Bill & Melinda Gates Foundation. With the pending massive cash infusion from one Warren Buffet, the Foundation is altering its internal financial structure to cleanly separate its program work from investment of its assets. Additionally, the foundation has also set time limit on the money, requiring that the funds be spent within 50 years of the deaths of both Gates. The foundation expects to steeply increase its grant-making from the current level of $1.75 billion per year to $3.5 billion by 2009. Its giving is focused in the areas of global health, global development, education and technology in public libraries.

Read the full story here.
Learn more about the Gates Foundation here.

Related Blogs

 

Just because it's new, doesn't make it better
Ibuprofen 400 mg used with permission from Daisy The Fall season of the MaRS Drug Discovery Discussion Group launched this week with resident CSO, Dr. Ed Nemeth of NPS Pharmaceuticals, talking about

Why the US mid-term elections matter to the Canadian pharma industry
Take the Pill, originally uploaded by messyatwork The upcoming US Congress and Senate mid-term elections will have far-reaching, unforeseen consequences, whatever the result may be. The President a

Having been there before, two congressmen tackle biotech generics
Ibuprofen 400 mg, used with permission from Daisy Having first been reported in the Philadelphia Inquirer, it appears that the US congress is about to tackle the thorny issue of biotech generics. Co

For only $125M, electronic medical records for Ontarians (by 2008)
Ontario Smart Systems for Health Agency The Toronto Star reports that basic electronic health records could be established by 2008 with an upfront investment of $125 million and ongoing investments

Could bankers partner with governments?
Two pieces of news grabbed my attention last week: MDS sold its Canadian lab business to Borealis Infrastructure; and A report from Buyouts magazine (subscription required) about a very, very healthy

Receptor Therapeutics raises $500,000
Receptor Therapeutics Inc. – a MaRS tenant – has raised $500,000 from the OICR’s IPDC Program via its OncoTek Drug Delivery Inc. subsidiary. The funds will be used to drive the pre

Tags: charities, finance, health care, Kevin Downing